Generex agrees Oral-lyn licensing with Dongsung Pharmaceuticals
This article was originally published in Scrip
Executive Summary
US company GenerexBiotechnology has signed a licensing agreement with Dong Sung Pharmaceutical for Dong to market, distribute and sell Generex Oral-lyn, Generex's proprietary oral insulin spray, in South Korea.